Elevated baseline LDH levels predict worse clinical outcomes in heart failure with reduced ejection fraction and modestly ...
Oral anticoagulant use was associated with a reduced risk for progression of 60% and a reduced risk for death of 76% in ...
Should New HEPZATO Subgroup Data and Delcath’s Targeted Strategy Require Action From DCTH Investors?
Delcath Systems announced that subgroup analyses from its phase 3 FOCUS study of the FDA-approved HEPZATO KIT for unresectable metastatic uveal melanoma were published in the Journal of Cancer ...
The treatment for acquired thrombotic thrombocytopenic purpura, a rare blood disorder that causes blood clots in the small ...
A subgroup analysis of the phase 3 FOCUS study (NCT02678572) shows that the Melphalan/Hepatic Delivery System (HDS; HEPZATO KIT) has a favorable benefit-risk profile for patients with metastatic uveal ...
Caplacizumab is a von Willebrand factor (vWF)-directed antibody fragment designed to inhibit the interaction between vWF and platelets.
Blood lactate is influenced by a wide range of metabolic processes. Blood lactate—much like central venous pressure—can ...
A study published in the American Journal of Human Biology suggests that Western medical standards for male testosterone ...
SAN FRANCISCO (KGO) -- After last week's rain, we are in great shape for our water year so far. Most neighborhoods are above normal when it comes to rainfall levels for the first three months of the ...
A nearly 30-year study shows a strong long-term association between very high lipoprotein(a) levels and cardiovascular ...
Doctors often say labs look “normal.” Dr. Mark Hyman explains why that doesn’t always reflect wellness, and what early ...
The optimal hydroxychloroquine blood level in lupus is between 750 ng/mL and 1,150 ng/mL, which can help prevent active ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback